Itron, Inc. (ITRI) Receives $80.00 Average PT from Brokerages
Shares of Itron, Inc. (NASDAQ:ITRI) have received an average rating of “Buy” from the eleven research firms that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $80.00.
A number of equities research analysts have commented on the company. Cowen and Company set a $60.00 price objective on Itron and gave the company a “hold” rating in a research note on Friday, July 21st. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $78.00 price objective (up previously from $75.00) on shares of Itron in a research note on Friday. Robert W. Baird reissued an “outperform” rating and issued a $73.00 price objective on shares of Itron in a research note on Thursday, July 13th. BidaskClub cut Itron from a “strong-buy” rating to a “buy” rating in a research note on Thursday, July 27th. Finally, Guggenheim assumed coverage on Itron in a research note on Tuesday, June 20th. They issued a “buy” rating and a $81.00 price objective for the company.
Several hedge funds and other institutional investors have recently made changes to their positions in ITRI. LS Investment Advisors LLC boosted its position in shares of Itron by 56.2% in the first quarter. LS Investment Advisors LLC now owns 1,892 shares of the scientific and technical instruments company’s stock valued at $115,000 after buying an additional 681 shares during the last quarter. SG Americas Securities LLC boosted its position in shares of Itron by 1.5% in the first quarter. SG Americas Securities LLC now owns 2,366 shares of the scientific and technical instruments company’s stock valued at $144,000 after buying an additional 36 shares during the last quarter. Envestnet Asset Management Inc. boosted its position in shares of Itron by 21.7% in the first quarter. Envestnet Asset Management Inc. now owns 2,492 shares of the scientific and technical instruments company’s stock valued at $152,000 after buying an additional 444 shares during the last quarter. Ameritas Investment Partners Inc. bought a new position in shares of Itron during the first quarter valued at about $175,000. Finally, Everence Capital Management Inc. bought a new position in shares of Itron during the second quarter valued at about $213,000. 94.63% of the stock is currently owned by institutional investors.
Shares of Itron (NASDAQ ITRI) remained flat at $73.05 during trading on Friday. 242,589 shares of the company traded hands. The firm’s 50-day moving average price is $70.53 and its 200-day moving average price is $65.22. The stock has a market capitalization of $2.83 billion, a PE ratio of 90.41 and a beta of 1.10. Itron has a 12-month low of $40.53 and a 12-month high of $75.60.
Itron (NASDAQ:ITRI) last issued its earnings results on Wednesday, August 2nd. The scientific and technical instruments company reported $0.71 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.03. The business had revenue of $503.10 million during the quarter, compared to the consensus estimate of $491.80 million. Itron had a return on equity of 15.43% and a net margin of 1.60%. The firm’s revenue for the quarter was down 1.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.65 earnings per share. On average, equities research analysts predict that Itron will post $3.07 EPS for the current fiscal year.
Itron, Inc (Itron) is a technology and service company. The Company provides solutions that measure, manage and analyze energy and water use. The Company operates through three segments: Electricity, Gas and Water. It provides a portfolio of products, solutions, software and services to electric, gas and water utility customers across the globe.
Receive News & Ratings for Itron Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron Inc. and related companies with MarketBeat.com's FREE daily email newsletter.